Gilead Sciences Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 6.6B 6.0B 5.7B 6.5B
Cost of revenue 1.3B 1.3B 1.3B 1.3B
Gross profit 5.3B 4.8B 4.4B 5.1B
Operating expense
Research & development 1.1B 1.3B 1.2B 1.4B
Selling general and admin 1.2B 1.2B 1.1B 1.6B
Other operating expenses
Operating income 3.0B 2.3B 2.1B 2.1B
Non operating interest income
Income 75.0M 62.2M 80.1M 72.5M
Expense 218.2M 216.5M 221.6M 212.3M
Other income expense 266.0M -98.0M -575.4M -93.8M
Pretax income 3.1B 2.1B 1.4B 1.8B
Tax provision 502.1M 399.0M 284.7M 328.2M
Net income 2.6B 1.7B 1.1B 1.5B
Basic EPS 1.6 1.1 1.4
Diluted EPS 1.6 1.0 1.4
Basic average shares 1.1B 1.1B 1.1B
Diluted average shares 1.1B 1.1B 1.1B
EBITDA 3.6B 3.0B 2.8B 2.7B
Net income from continuing op. 2.6B 1.7B 1.1B 1.5B
Minority interests 0 0 0 0
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 8 hours 44 minutes

23:15
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).